Harm Reduction

"Harm Reduction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The application of methods designed to reduce the risk of harm associated with certain behaviors without reduction in frequency of those behaviors. The risk-associated behaviors include ongoing and active addictive behaviors.

Descriptor ID	D040261
MeSH Number(s)	F01.145.477
Concept/Terms	Harm Reduction Harm Reduction Reduction, Harm Harm Minimization Minimization, Harm

Below are MeSH descriptors whose meaning is more general than "Harm Reduction".

Psychiatry and Psychology [F]
Behavior and Behavior Mechanisms [F01]
Behavior [F01.145]
Harm Reduction [F01.145.477]

Below are MeSH descriptors whose meaning is more specific than "Harm Reduction".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Harm Reduction" by people in this website by year, and whether "Harm Reduction" was a major or minor topic of these publications.

Bar chart showing 22 publications over 9 distinct years, with a maximum of 4 publications in 2017 and 2024 and 2025

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	1	2
2015	2	1	3
2016	0	1	1
2017	1	3	4
2018	1	0	1
2020	1	1	2
2023	1	0	1
2024	2	2	4
2025	3	1	4

Below are the most recent publications written about "Harm Reduction" by people in Profiles.

Pope E, Ameral V, Falc?n A, Smith J, Shoemaker-Hunt SJ, Bounthavong M, McCullough M, Kim B. Knowledge and attitudes regarding substance use disorder treatment and harm reduction practices among US pharmacists: A scoping review. J Am Pharm Assoc (2003). 2025 Sep-Oct; 65(5):102462.

View in: PubMed
Rioux W, Viste D, Sedaghat N, Rider N, Tek JTW, Perri M, Schwartz DG, Ritchie K, Carr? G, Carreiro S, Kreig O, Marcu G, Arthur J, Cogdell J, Brown M, Marshall T, Ghosh SM. Defining terminology and outcome measures for evaluating overdose response technology: An international Delphi study. Drug Alcohol Rev. 2025 Jul; 44(5):1430-1443.

View in: PubMed
Broach JP, Rettger B, Gigliotti R, Chapman BP, Joseph J, Smiley A, Hunter M, Soucie N, Gross K, Babu KM, Weisberg SN. Creating Opioid Response Specialists: A Harm Reduction Initiative. Prehosp Emerg Care. 2025; 29(4):540-545.

View in: PubMed
Ameral V, Sofuoglu M, Kelly MM. Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective. Expert Rev Clin Pharmacol. 2025 Apr; 18(4):189-196.

View in: PubMed
Martin R, DaCunha A, Bailey A, Joseph R, Kane K. Evaluating public health vending machine rollout and utilization in criminal-legal settings. J Subst Use Addict Treat. 2025 Feb; 169:209584.

View in: PubMed
Michener PS, Bianchet E, Fox S, Evans EA, Friedmann PD. "Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder. Harm Reduct J. 2024 07 22; 21(1):138.

View in: PubMed
Sibley AL, Klein E, Cooper HLF, Livingston MD, Baker R, Walters SM, Gicquelais RE, Ruderman SA, Friedmann PD, Jenkins WD, Go VF, Miller WC, Westergaard RP, Crane HM. The relationship between felt stigma and non-fatal overdose among rural people who use drugs. Harm Reduct J. 2024 04 06; 21(1):77.

View in: PubMed
Westafer LM, Beck SA, Simon C, Potee B, Soares WE, Schoenfeld EM. Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience. Ann Emerg Med. 2024 Apr; 83(4):340-350.

View in: PubMed
Davis A, Stringer KL, Drainoni ML, Oser CB, Knudsen HK, Aldrich A, Surratt HL, Walker DM, Gilbert L, Downey DL, Gardner SD, Tan S, Lines LM, Vandergrift N, Mack N, Holloway J, Lunze K, McAlearney AS, Huerta TR, Goddard-Eckrich DA, El-Bassel N. Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study. Int J Drug Policy. 2023 Dec; 122:104241.

View in: PubMed
Duvallet C, Hayes BD, Erickson TB, Chai PR, Matus M. Mapping Community Opioid Exposure Through Wastewater-Based Epidemiology as a Means to Engage Pharmacies in Harm Reduction Efforts. Prev Chronic Dis. 2020 08 20; 17:E91.

View in: PubMed

People

Explore

Similar Concepts

Top Journals